— Know what they know.
Not Investment Advice

SLNX OTC

Solanbridge Group, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +400.0% 1Y: +400.0% 3Y: -50.0% 5Y: -66.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $476000 mcap · 3.27B float · 0.038% daily turnover

Balance Sheet Trends

Total Assets
$4 +4.6% ▲
5Y CAGR: -84.6%
Total Liabilities
$95 +252.2% ▲
5Y CAGR: -79.4%
Shareholders Equity
-$91 -289.2% ▼
Cash & Investments
$0 +0.0% ▲
Total Debt
$15 +92.0% ▲
5Y CAGR: -85.7%
Net Debt
$15 +92.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$100$100$100$0$0
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$100$100$100$0$0
Net Receivables$0$0$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$4$4
Total Current Assets$100$100$100$4$4
Property, Plant & Equip.$42K$42K$42K$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$42K$42K$42K$0$0
Total Assets$43K$43K$43K$4$4
— Liabilities —
Accounts Payable$0$0$0$0$80K
Short-Term Debt$253K$253K$253K$8$15
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$16-$80K
Total Current Liabilities$253K$253K$253K$27$95
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$253K$253K$253K$27$95
— Equity —
Common Stock$24K$24K$24K$17K$17K
Retained Earnings-$2M-$2M-$2M-$17K-$17K
Accumulated OCI$27K$27K$27K$0-$48K
Total Stockholders Equity-$230K-$236K-$243K-$23-$91
Total Liabilities & Equity$23K$17K$10K$4$4
— Key Metrics —
Total Debt$253K$253K$253K$8$15
Net Debt$253K$253K$253K$8$15
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms